Collaborate Disseminate
Research into clinical uses for psychedelics has proliferated in recent years, but despite the constant stream of “psychedelic renaissance” news, the vast majority of studies remain in early, preliminary stages. Apart from one notable modality (MDMA-as… Continue reading The world’s first Phase 3 psilocybin clinical trial is about to commence
New research from a team of economists has estimated the legalization of medical and recreational cannabis over the past 25 years has cost pharmaceutical companies billions of dollars in lost sales. And, if the US were to legalize cannabis across the w… Continue reading Cannabis legalization in US projected to cost big pharma billions
New research from a team of economists has estimated the legalization of medical and recreational cannabis over the past 25 years has cost pharmaceutical companies billions of dollars in lost sales. And, if the US were to legalize cannabis across the w… Continue reading Cannabis legalization in US projected to cost big pharma billions
For almost a century popular culture has been filled with images of lazy, unmotivated “stoners” who do little more with their lives than smoke cannabis, but a new study from a team of UK researchers is busting that long-held myth. Across a series of la… Continue reading Study debunks “stoner” myth that cannabis users are lazy & unmotivated
A new study published in JAMA Psychiatry has reported results from the first ever double-blind, placebo-controlled trial testing psilocybin-assisted psychotherapy to treat alcohol use disorder. The headline results are promising, finding nearly half of… Continue reading Psilocybin alcoholism trial highlights problem for psychedelic science
New data from an annual drug-use survey supported by the US National Institutes of Health has found recreational use of psychedelics among older adults in the US is at the highest point ever-recorded in the survey’s nearly 40-year history. The data als… Continue reading Annual US drug survey finds use of psychedelics at a record high
A pair of unassuming Australian psychedelic researchers are proposing a radical paradigm shift to the way psychotherapy is conducted. The pair have developed a unique protocol for incorporating virtual reality into the still experimental mode of psyche… Continue reading Meet two researchers bringing VR to psychedelic therapy
A first-of-its-kind trial exploring MDMA-assisted therapy in a group setting is about to commence following the resolution of a clinical hold placed by the US Food and Drug Administration (FDA) that paused progress for several months. The goal of the g… Continue reading First-of-its-kind MDMA group therapy trial set to commence
Biopharmaceutical company MindMed has announced the first topline data from a novel Phase 2 trial testing high doses of LSD as a treatment for anxiety. The results indicate one to two LSD sessions can generate rapid and sustained reductions to anxiety,… Continue reading Promising early results from largest-ever trial testing LSD for anxiety
An ongoing study is testing a new kind of neuroimaging device designed to easily capture brain activity in real-time. These preliminary experiments will investigate the effects of ketamine on functional connectivity in the brain before, during and afte… Continue reading Brain imaging helmet tracks psychedelic experiences in ketamine study